Clot regression effects of rivaroxaban in the treatment of venous thromboembolism in patients with cancer (CRERIT-VTE cancer): study protocol

INTRODUCTION: Anticoagulant therapy in patients with cancer with venous thromboembolism (VTE) increases the risk of both VTE recurrence and haemorrhagic complication. Direct oral anticoagulants (DOACs) have been shown to be effective in preventing VTE recurrence, and comparable to conventional thera...

Descripción completa

Detalles Bibliográficos
Autores principales: Takai, Shigeki, Nakanishi, Naohiko, Yokota, Isao, Imai, Kojiro, Yamada, Ayumu, Kawasaki, Takanori, Okada, Takashi, Sawada, Takahisa, Fujita, Hiroshi, Matoba, Satoaki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2019
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858172/
https://www.ncbi.nlm.nih.gov/pubmed/31694850
http://dx.doi.org/10.1136/bmjopen-2019-031698

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858172/
https://www.ncbi.nlm.nih.gov/pubmed/31694850
http://dx.doi.org/10.1136/bmjopen-2019-031698

Ejemplares similares